Melinda! What great news! You are free, free, free as a bird forever!
Thanks for posting your update... you made my night !
Big smiles, and even bigger hugs. Congrats! ~eureka
that is wonderful news. Makes this treatment well worth it!
Congrats on the long term SVR, it looks like no worries any longer.
- Dave
WHOO HOO! Congratulations. Add another hash mark to the tally!
congrat HOORAY !!! adidos dragon!!!!YEAH....
Being new here and seeing such great end results like you had, gives hope to those like me that are just starting this journey. I am happy for you, and I look forward to the same celebration one day in the not too distant future. It's story's like yours that help me feel that I can do this.
Thanks, Bree
Congrats, Melinda! It's great to hear about this.
Regards and best wishes,
Susan
Follow-up is recommended even after SVR.
Co
June 2010
Relapse of hepatitis C in a pegylated-interferon-alpha-2b plus ribavirin-treated sustained virological responder.
Fujii H, Itoh Y, Ohnishi N, Sakamoto M, Ohkawara T, Sawa Y, Nishida K, Nishimura T, Yamaguchi K, Yasui K, Minami M, Okanoue T, Ohkawara Y, Yoshikawa T.
Department of Internal Medicine, Aiseikai Yamashina Hospital, Kyoto, Japan.
Abstract
A 41-year-old woman with chronic hepatitis C was treated with pegylated-interferon (PEG-IFN)-alpha-2b plus ribavirin for 24 weeks. She had hepatitis C virus (HCV) genotype 2a (1600 KIU/mL), and her liver histology showed mild inflammation and fibrosis. Four weeks after the start of the therapy, she achieved a rapid virological response (RVR) and then a sustained virological response (SVR). Serum alanine aminotransferase (ALT) levels remained within normal ranges and HCV RNA continued to be negative. However, ALT levels flared with the re-emergence of HCV RNA in the serum 1.5 years after discontinuation of therapy. HCV RNA obtained from sera before therapy and after relapse shared a 98.6% homology with the E2 region, and phylogenetic analyses indicated that they were the same HCV strain. These results eliminated the possibility of a re-infection and strongly indicated a late relapse of the disease. Therefore, follow-up is necessary for chronic hepatitis C patients after SVR, even if they respond well to therapy, including RVR.
http://www.ncbi.nlm.nih.gov/pubmed/20618461
Now that was a study I did not want to ever see appear.
Kill joy. TTTHHHPPPTTT! ~MM
Congrats MM! I just got my 2 year back and am also UND.It's important to get yearly PCR's but I KNOW the dragon is DEAD! WooWhoo!